Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: DCB001
MIFTS: 45

Decubitus Ulcer

Categories: Skin diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Decubitus Ulcer

About this section

MalaCards integrated aliases for Decubitus Ulcer:

Name: Decubitus Ulcer 12 15
Pressure Ulcer 12 55 44 73
Pressure Sores 12 43
Decubitus Ulcer, Lower Back 12
Decubitus Ulcer, Other Site 12
Decubitus Ulcer, Upper Back 12
Decubitus Ulcer Any Site 12
Decubitus Ulcer, Elbow 12
Decubitus Ulcer 12
Pressure Ulcers 63
Bedsore 12

Classifications:

MalaCards categories:
Anatomical: Skin diseases
See all MalaCards categories (disease lists)
ICD10: 33


Sources

Summaries for Decubitus Ulcer

About this section
MedlinePlus : 43 Pressure sores are areas of damaged skin caused by staying in one position for too long. They commonly form where your bones are close to your skin, such as your ankles, back, elbows, heels and hips. You are at risk if you are bedridden, use a wheelchair, or are unable to change your position. Pressure sores can cause serious infections, some of which are life-threatening. They can be a problem for people in nursing homes. You can prevent the sores by Keeping skin clean and dry Changing position every two hours Using pillows and products that relieve pressure Pressure sores have a variety of treatments. Advanced sores are slow to heal, so early treatment is best.

MalaCards based summary : Decubitus Ulcer, also known as pressure ulcer, is related to bacterial meningitis and endocarditis, and has symptoms including exanthema and pruritus. An important gene associated with Decubitus Ulcer is TTR (Transthyretin), and among its related pathways/superpathways is FOXA2 and FOXA3 transcription factor networks. The drugs Ketamine and Nitric Oxide have been mentioned in the context of this disorder. Affiliated tissues include skin, spinal cord and lung.

Disease Ontology : 12 Decubitus ulcer is a chronic ulcer of skin where the ulcer is an ulceration of tissue deprived of adequate blood supply by prolonged pressure.

PubMed Health : 63 About pressure ulcers: Some people inevitably spend a lot of time in a sitting or lying position. Most of them keep moving and shifting a little, consciously or subconsciously. But people who are extremely weak, paralyzed or unconscious may sit or lie motionless in the same position for a very long time. This puts them at greater risk of developing pressure ulcers (also called bedsores or pressure sores), which are open wounds caused by persistent external pressure against the skin. They can be very painful and usually take a long time to heal.

Wikipedia : 76 Pressure ulcers, also known as pressure sores, pressure injuries, bedsores, and decubitus ulcers, are... more...

Sources

Related Diseases for Decubitus Ulcer

About this section

Diseases related to Decubitus Ulcer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 77)
# Related Disease Score Top Affiliating Genes
1 bacterial meningitis 29.8 ALB CRP
2 endocarditis 29.1 ALB CRP
3 ulcer of lower limbs 11.1
4 paramyloidosis 10.8 ALB TTR
5 burns 10.7 ALB TTR
6 kwashiorkor 10.7 ALB TTR
7 marasmus 10.7 ALB TTR
8 aleutian mink disease 10.7 ALB TTR
9 hyperthyroxinemia 10.7 ALB TTR
10 autonomic nervous system disease 10.7 ALB TTR
11 diffuse glomerulonephritis 10.7 ALB FGF2
12 protein-energy malnutrition 10.6 ALB TTR
13 demyelinating polyneuropathy 10.6 ALB TTR
14 testicular yolk sac tumor 10.6 ALB TTR
15 abdominal tuberculosis 10.5 ALB CRP
16 pyuria 10.5 ALB CRP
17 amyloidosis aa 10.5 CRP TTR
18 hypersensitivity reaction type iii disease 10.4 ALB CRP
19 tuberculous peritonitis 10.4 ALB CRP
20 obstructive jaundice 10.4 ALB TTR
21 acute cystitis 10.4 ALB CRP
22 peptic ulcer perforation 10.4 ALB CRP
23 prediabetes syndrome 10.4 ALB CRP
24 pleural disease 10.4 ALB CRP
25 acute pyelonephritis 10.4 ALB CRP
26 diverticulitis 10.4 CRP FGF2
27 hemorrhagic fever with renal syndrome 10.4 ALB CRP
28 intermittent claudication 10.3 ALB CRP
29 proctitis 10.3 CRP FGF2
30 interstitial nephritis 10.3 ALB CRP
31 bone fracture 10.3 CRP FGF2
32 heart conduction disease 10.3 CRP TTR
33 pericardial effusion 10.3 CRP FGF2
34 pyelonephritis 10.3 ALB CRP
35 typhoid fever 10.2 ALB CRP
36 appendicitis 10.2 ALB CRP
37 leukocyte disease 10.2 ALB CRP
38 coronary stenosis 10.2 ALB CRP
39 analbuminemia 10.2 ALB CRP TTR
40 dysentery 10.2 ALB CRP TTR
41 nutritional deficiency disease 10.2 ALB CRP TTR
42 acquired metabolic disease 10.1 ALB CRP TTR
43 respiratory failure 10.1 ALB CRP TTR
44 chronic kidney failure 10.1 ALB CRP TTR
45 homocysteinemia 10.0 ALB CRP
46 spinal cord injury 10.0
47 gastroenteritis 10.0 ALB CRP
48 meningitis 9.9
49 vascular disease 9.9 ALB CRP FGF2
50 primary bacterial infectious disease 9.8 ALB CRP

Comorbidity relations with Decubitus Ulcer via Phenotypic Disease Network (PDN): (show top 50) (show all 109)


Acquired Thrombocytopenia Active Peptic Ulcer Disease
Acute Conjunctivitis Acute Cystitis
Acute Kidney Failure Acute Myocardial Infarction
Acute Vascular Insufficiency of Intestine Alzheimer Disease
Aortic Valve Disease 1 Bacteremia 2
Bronchitis Bronchopneumonia
Bullous Pemphigoid Candidiasis
Cardiac Arrest Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Kidney Failure Chronic Myocardial Ischemia
Chronic Ulcer of Skin Communicating Hydrocephalus
Conjunctivitis Cystitis
Deficiency Anemia Dermatomycosis
Diabetes Mellitus, Ketosis-Prone Diabetes Mellitus, Noninsulin-Dependent
Diabetic Polyneuropathy Disseminated Intravascular Coagulation
Encephalopathy Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Erythematosquamous Dermatosis Esophageal Candidiasis
Esophageal Disease Familial Atrial Fibrillation
Fecal Incontinence Femoral Vein Thrombophlebitis
Folic Acid Deficiency Anemia Gas Gangrene
Generalized Atherosclerosis Heart Disease
Hepatic Encephalopathy Hydronephrosis
Hypertension, Essential Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis Syndrome
Hypoglycemia Hypoglycemic Coma
Hypothyroidism Intestinal Obstruction

Graphical network of the top 20 diseases related to Decubitus Ulcer:



Diseases related to Decubitus Ulcer
Sources

Symptoms & Phenotypes for Decubitus Ulcer

About this section

UMLS symptoms related to Decubitus Ulcer:


exanthema, pruritus
Sources

Drugs & Therapeutics for Decubitus Ulcer

About this section

PubMedHealth treatment related to Decubitus Ulcer: 63

As much pressure as possible should be taken off of the pressure ulcer. The most important thing is to stop sitting or lying on the wound. Special positioning aids, special soft mattresses, and regular repositioning and movement help to relieve the pressure.Sterile wound dressings are usually used to protect the wound and help it to heal. If necessary, the wound is also regularly cleaned and dead tissue removed. The most appropriate treatment will depend on the type and severity of the pressure ulcer.

Drugs for Decubitus Ulcer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 245)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
2
Nitric Oxide Approved Phase 4,Phase 1,Phase 2,Not Applicable 10102-43-9 145068 160954
3
Benzocaine Approved, Investigational Phase 4,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
4
Petrolatum Approved, Investigational Phase 4,Not Applicable 8009-03-8
5
Zinc Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 7440-66-6 23994
6
Metformin Approved Phase 4 657-24-9 14219 4091
7
Sevoflurane Approved, Vet_approved Phase 4,Phase 2,Not Applicable 28523-86-6 5206
8
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 2180-92-9, 38396-39-3 2474
9
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
10
Midazolam Approved, Illicit Phase 4,Phase 2,Phase 3,Not Applicable 59467-70-8 4192
11
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 71273 175805
12
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
13
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
14
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
15
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 51-43-4 5816
16
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 437-38-7 3345
17
Insulin Glargine Approved Phase 4 160337-95-1
18
Linagliptin Approved Phase 4 668270-12-0 10096344
19
Prilocaine Approved Phase 4,Not Applicable 721-50-6 4906
20 Titanium dioxide Approved Phase 4 13463-67-7
21
Racepinephrine Approved Phase 4,Phase 2,Phase 3,Not Applicable 329-65-7 838
22
Alginic acid Approved, Investigational Phase 4,Phase 3 9005-32-7
23
Ephedrine Approved Phase 4 299-42-3 9294
24
Pseudoephedrine Approved Phase 4 90-82-4 7028
25
Norepinephrine Approved Phase 4 51-41-2 439260
26
Phenylephrine Approved Phase 4 59-42-7 6041
27
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
28
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
29
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
30
Thrombin Approved, Investigational Phase 4,Not Applicable
31
acetic acid Approved, Nutraceutical Phase 4 64-19-7 176
32 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Not Applicable
33
St. John's Wort Approved, Investigational, Nutraceutical Phase 4 84082-80-4
34
Vitamin C Approved, Nutraceutical Phase 4,Not Applicable 50-81-7 5785 54670067
35
Synephrine Experimental Phase 4 1994-07-5, 94-07-5 7172
36
Bismuth Phase 4,Not Applicable 7440-69-9 16682734 105143
37
Retinol acetate Phase 4 127-47-9 10245972
38 Analgesics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
39 Respiratory System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
40 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
41 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
43 Anesthetics, Dissociative Phase 4
44 Anesthetics, General Phase 4,Phase 2
45 Dermatologic Agents Phase 4,Not Applicable
46 Anesthetics, Intravenous Phase 4,Phase 2
47 Anti-Asthmatic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
48 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
49 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
50 Excitatory Amino Acid Antagonists Phase 4

Interventional clinical trials:

(show top 50) (show all 504)
# Name Status NCT ID Phase Drugs
1 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
2 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
3 Wound Management for Sacral Pressure Ulcers With Necrotic Tissue Unknown status NCT02224638 Phase 4
4 Ketamine and Refractory Painful Care in a Palliative Unit Unknown status NCT02587130 Phase 4 Ketamine
5 Clinical Evaluation of the SNaP Wound Care System Unknown status NCT01113658 Phase 4
6 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
7 Negative Pressure Wound Therapy With the Engenexâ„¢-Pump and Bio-Domeâ„¢ Dressing, an Evaluation Unknown status NCT01107821 Phase 4
8 Pressure Ulcer Healing With Microcyn Completed NCT02001558 Phase 4 Microcyn
9 Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease Completed NCT01555593 Phase 4
10 Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation Completed NCT02526862 Phase 4
11 Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Between Prone and Left Lateral Decubitus Completed NCT01599351 Phase 4
12 Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients Completed NCT01356732 Phase 4 Sufentanil
13 A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration Completed NCT01438541 Phase 4
14 Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers Completed NCT00521027 Phase 4
15 The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function Completed NCT01547416 Phase 4 epidural 250mL of 0.2% ropivacaine and 2 μg/mL of fentanyl, 5 mL/hr continuous infusion and 0.5 mL bolus dose;no epidural drug administered
16 Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Completed NCT01036438 Phase 4
17 Femoral Blockade and Low-dose Spinal Anesthesia in Outpatient Knee Arthroscopy Completed NCT02322372 Phase 4 Femoral blockade;Intrathecal anesthesia
18 Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics Completed NCT02185339 Phase 4 Rocuronium;Rocuronium
19 Spinal Anesthesia Versus Combined Sciatic-femoral Nerve Block for Outpatient Knee Arthroscopy Completed NCT02384915 Phase 4 prilocaine;mepivacaine
20 Surgical Approach Affect on Post-operative Analgesic Requirement Following Laparoscopic Nephrectomy Completed NCT02622893 Phase 4 Transperitoneal laparoscopic nephrectomy;Retroperitoneal laparoscopic nephrectomy
21 Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant Completed NCT02781779 Phase 4
22 Mesoglycan, Vascular Reactivity and Metabolic Syndrome Completed NCT02254850 Phase 4 Mesoglycan;Mesoglycan;Placebo;Placebo
23 ADA Linagliptin in Long Term Care Completed NCT02061969 Phase 4 linagliptin;insulin glargine
24 Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst Recruiting NCT02485860 Phase 4
25 Fibrinolytic Therapy Versus Medical Thoracoscopy Recruiting NCT03213834 Phase 4 tPA;DNase
26 Vasoactive Drugs in Intensive Care Unit Recruiting NCT02118467 Phase 4 Norepinephrine;Epinephrine;Phenylephrine;Vasopressin
27 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors Active, not recruiting NCT03098368 Phase 4 Rotigotine;Placebo
28 Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics. Not yet recruiting NCT03322878 Phase 4 Magnesium SO4
29 Does the Preoperative Midazolam Dose Affect Postoperative Pain? Not yet recruiting NCT03534895 Phase 4 Midazolam Injectable Solution;Postoperative analgesia;Rescue analgesia;Wound infiltration;Analgesia at home
30 Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers Terminated NCT02718625 Phase 4
31 Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds Terminated NCT00691821 Phase 4
32 Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip Terminated NCT01593319 Phase 4 Ropivacaine;Natrium chloride
33 Manuka Honey for Wound Care Terminated NCT02259491 Phase 4 Manuka Honey Dressing
34 Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers Withdrawn NCT02689310 Phase 4
35 A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers Withdrawn NCT02248077 Phase 4
36 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
37 PEMF Effects on Pain After Abdominal Body Contouring Withdrawn NCT01762423 Phase 4
38 A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites Withdrawn NCT02994589 Phase 4
39 Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions Unknown status NCT02711839 Phase 2, Phase 3
40 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3
41 Pressure Ulcer Prevention Study in SCI Completed NCT01999816 Phase 3
42 Pressure Ulcer Prevention: Turning for Ulcer Reduction Completed NCT00665535 Phase 3
43 Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens Completed NCT00847665 Phase 3
44 Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers Completed NCT01008254 Phase 2, Phase 3
45 Informativeness to Digital Rectal Examination Completed NCT01727388 Phase 3
46 Pressure Ulcer Multi-disciplinary Teams Via Telemedicine (PUMTT): A Trial in Long Term Care Completed NCT01232764 Phase 3
47 Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study Completed NCT00796042 Phase 3
48 Efficacy of Prontosan Solution on Chronic Ulcers Completed NCT01333670 Phase 3 Isotonic solution (saline or lactated ringer)
49 Maggot Therapy for Wound Debridement Completed NCT01211236 Phase 3
50 Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Completed NCT01214811 Phase 3

Search NIH Clinical Center for Decubitus Ulcer

Cochrane evidence based reviews: pressure ulcer

Sources

Genetic Tests for Decubitus Ulcer

About this section
Sources

Anatomical Context for Decubitus Ulcer

About this section

MalaCards organs/tissues related to Decubitus Ulcer:

41
Skin, Spinal Cord, Lung, Bone, Breast, Colon, Prostate
Sources

Publications for Decubitus Ulcer

About this section

Articles related to Decubitus Ulcer:

(show top 50) (show all 221)
# Title Authors Year
1
Outcome analyses of a multimodal treatment approach for deep pressure ulcers in spinal cord injuries: a retrospective cohort study. ( 29386657 )
2018
2
Fourier's gangrene associated with a decubitus ulcer. ( 29942775 )
2018
3
Predictive Value of Braden Risk Factors in Pressure Ulcers of Outpatients With Spinal Cord Injury. ( 29436796 )
2018
4
The application of negative pressure wound therapy combined with compression bandaging for the decubitus ulcer of an advanced primary lower limb lymphedema. ( 28244063 )
2017
5
Surgery for pressure ulcers in spinal cord-injured patients following a structured treatment programme: a 10-year follow-up. ( 27146601 )
2017
6
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817452 )
2017
7
Assessment of the extension of pressure ulcers into soft tissue and osteomyelitis diagnosis using<sup>18</sup>F-FDG PET/CT. ( 28341229 )
2017
8
Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3'-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers. ( 29241179 )
2017
9
Inflammatory Mediators Associated With Pressure Ulcer Development in Individuals With Pneumonia After Traumatic Spinal Cord Injury: A Pilot Study. ( 28130082 )
2017
10
Caudal Regression Syndrome with Pressure Ulcers of the Foot: A Case Report. ( 28892975 )
2017
11
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817454 )
2017
12
Bacterial load of conditioned pressure ulcers is not a predictor for early flap failure in spinal cord injury. ( 28071687 )
2017
13
Does the Acute Care Spinal Cord Injury Setting Predict the Occurrence of Pressure Ulcers at Arrival to Intensive Rehabilitation Centers? ( 26418488 )
2016
14
Early Detection of Pressure Ulcer Development Following Traumatic Spinal Cord Injury Using Inflammatory Mediators. ( 26820323 )
2016
15
The role of habit in recurrent pressure ulcers following spinal cord injury. ( 26763555 )
2016
16
A Case of Extensive Sacral Decubitus Ulcer Complicated by an Epidural Abscess. ( 27536469 )
2016
17
Pneumorrhachis Secondary to a Sacral Decubitus Ulcer. ( 27429699 )
2016
18
Developing a Model of Care for Healing Pressure Ulcers With Electrical Stimulation Therapy for Persons With Spinal Cord Injury. ( 29339869 )
2016
19
Soft silicone foam dressing is more effective than polyurethane film dressing for preventing intraoperatively acquired pressure ulcers in spinal surgery patients: the Border Operating room Spinal Surgery (BOSS) trial in Japan. ( 27928911 )
2016
20
Self-management interventions to improve skin care for pressure ulcer prevention in people with spinal cord injuries: a systematic review protocol. ( 27600153 )
2016
21
Design of mechanical interface to re-distribute excess pressure to prevent the formation of decubitus ulcers in bed ridden patients. ( 26736438 )
2015
22
A randomised controlled trial of the effectiveness of soft silicone multi-layered foam dressings in the prevention of sacral and heel pressure ulcers in trauma and critically ill patients: the border trial. ( 23711244 )
2015
23
Oestrogen-soaked vaginal packing for decubitus ulcer in advanced pelvic organ prolapse: a case series. ( 26718780 )
2015
24
Factors Associated With Pressure Ulcers in Individuals With Spina Bifida. ( 25796136 )
2015
25
Usefulness of Simple-Designed Bilobed Flap for Reconstruction of Ischial Decubitus Ulcer. ( 26495238 )
2015
26
Psychometric Properties of the Spinal Cord Injury Pressure Ulcer Scale (SCIPUS) for Pressure Ulcer Risk Assessment During Inpatient Rehabilitation. ( 26205694 )
2015
27
Pilot study compares scores of the Resident Assessment Instrument Minimum Data Set Version 2.0 (MDS 2.0) Pressure Ulcer Risk Scale with the Braden Pressure Ulcer Risk assessment for patients in complex continuing care. ( 25502973 )
2015
28
Hospital beds wireless sensor network and reducing decubitus ulcer. ( 26600842 )
2015
29
Bacteriology of pressure ulcers in individuals with spinal cord injury: What we know and what we should know. ( 25130374 )
2015
30
Prevention of Pressure Ulcers Among People With Spinal Cord Injury: A Systematic Review. ( 25529614 )
2015
31
Surgical Treatment of Pressure Ulcers with a Fibrin Sealant in Patients with Spinal Cord Injury: A Cost-Consequence Analysis. ( 26479693 )
2015
32
Lifestyle risk factors for pressure ulcers in community-based patients with spinal cord injuries in Japan. ( 25665536 )
2015
33
Verrucous carcinoma on a chronic sacral pressure ulcer in a patient with meningomyelocele. Case report and review of the literature. ( 25661446 )
2015
34
Role of local application of autologous platelet-rich plasma in the management of pressure ulcers in spinal cord injury patients. ( 25179658 )
2014
35
Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy. ( 25422898 )
2014
36
Spinal subdural abscess: a rare complication of decubitus ulcer. ( 24667217 )
2014
37
A modified total thigh flap in the reconstruction of decubitus ulcer. ( 25075377 )
2014
38
Perioperative use of bispectral (BIS) monitor for a pressure ulcer patient with locked-in syndrome (LIS). ( 25252146 )
2014
39
Subepidermal moisture surrounding pressure ulcers in persons with a spinal cord injury: A pilot study. ( 25398030 )
2014
40
The combination application of space filling and closed irrigation suction in reconstruction of sacral decubitus ulcer. ( 25216432 )
2014
41
Squamous Cell Carcinoma (Marjolin's Ulcer) Arising in a Sacral Decubitus Ulcer Resulting in Humoral Hypercalcemia of Malignancy. ( 25197285 )
2014
42
Prevalence, location, grade of pressure ulcers and association with specific patient characteristics in adult spinal cord injury patients during the hospital stay: a prospective cohort study. ( 23999106 )
2013
43
Cerebrospinal fluid leak masquerading as a decubitus ulcer in a patient with spina bifida. ( 24324852 )
2013
44
Interobserver agreement of magnetic resonance imaging signs of osteomyelitis in pelvic pressure ulcers in patients with spinal cord injury. ( 23164978 )
2013
45
Fabric-based pressure sensor array for decubitus ulcer monitoring. ( 24111232 )
2013
46
Meningitis with pneumocephalus originating from a sacral pressure ulcer. ( 24042536 )
2013
47
Comprehensive management of pressure ulcers in spinal cord injury: Current concepts and future trends. ( 24090179 )
2013
48
Pressure ulcer in patients with severe traumatic brain injury: significant factors and association with neurological outcome. ( 24112115 )
2013
49
Identifying and classifying quality-of-life tools for assessing pressure ulcers after spinal cord injury. ( 24090238 )
2013
50
Severe sensory neuropathy increases risk of heel pressure ulcer in older adults. ( 24219213 )
2013
Sources

Variations for Decubitus Ulcer

About this section
Sources

Expression for Decubitus Ulcer

About this section
Search GEO for disease gene expression data for Decubitus Ulcer.
Sources

Pathways for Decubitus Ulcer

About this section

Pathways related to Decubitus Ulcer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
FOXA2 and FOXA3 transcription factor networks 1
10.27 ALB TTR
Sources

GO Terms for Decubitus Ulcer

About this section
Sources

Sources for Decubitus Ulcer

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....